3,535 Shares in Core Laboratories N.V. (CLB) Purchased by Shelton Capital Management

Shelton Capital Management acquired a new position in Core Laboratories N.V. (NYSE:CLB) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 3,535 shares of the oil and gas company’s stock, valued at approximately $358,000.

Other institutional investors have also recently modified their holdings of the company. Clearbridge Investments LLC boosted its stake in Core Laboratories N.V. by 3.8% in the 1st quarter. Clearbridge Investments LLC now owns 5,219,879 shares of the oil and gas company’s stock worth $603,000,000 after purchasing an additional 190,186 shares in the last quarter. WCM Investment Management CA boosted its stake in Core Laboratories N.V. by 7.3% in the 2nd quarter. WCM Investment Management CA now owns 4,433,175 shares of the oil and gas company’s stock worth $448,948,000 after purchasing an additional 303,073 shares in the last quarter. Vanguard Group Inc. boosted its stake in Core Laboratories N.V. by 1.6% in the 2nd quarter. Vanguard Group Inc. now owns 3,672,865 shares of the oil and gas company’s stock worth $371,950,000 after purchasing an additional 56,807 shares in the last quarter. Sustainable Growth Advisers LP boosted its stake in Core Laboratories N.V. by 36.9% in the 2nd quarter. Sustainable Growth Advisers LP now owns 2,345,271 shares of the oil and gas company’s stock worth $237,505,000 after purchasing an additional 632,263 shares in the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC boosted its stake in Core Laboratories N.V. by 1.3% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,702,000 shares of the oil and gas company’s stock worth $172,364,000 after purchasing an additional 22,276 shares in the last quarter.

COPYRIGHT VIOLATION NOTICE: “3,535 Shares in Core Laboratories N.V. (CLB) Purchased by Shelton Capital Management” was originally reported by TrueBlueTribune and is owned by of TrueBlueTribune. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The correct version of this piece of content can be viewed at https://www.truebluetribune.com/2017/10/13/3535-shares-in-core-laboratories-n-v-clb-purchased-by-shelton-capital-management.html.

Shares of Core Laboratories N.V. (CLB) opened at 94.84 on Friday. The firm has a market capitalization of $4.19 billion, a PE ratio of 58.18 and a beta of 1.64. The firm’s 50-day moving average is $94.28 and its 200 day moving average is $102.37. Core Laboratories N.V. has a 52 week low of $86.55 and a 52 week high of $125.83.

Core Laboratories N.V. (NYSE:CLB) last announced its earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.01. The business had revenue of $163.90 million for the quarter, compared to analyst estimates of $168.23 million. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The company’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same period last year, the firm posted $0.35 earnings per share. On average, equities analysts forecast that Core Laboratories N.V. will post $1.98 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 21st. Stockholders of record on Friday, October 20th will be given a dividend of $0.55 per share. The ex-dividend date of this dividend is Thursday, October 19th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.32%. Core Laboratories N.V.’s dividend payout ratio (DPR) is presently 134.15%.

A number of research firms recently commented on CLB. Royal Bank Of Canada set a $145.00 target price on shares of Core Laboratories N.V. and gave the stock a “buy” rating in a research note on Saturday, June 17th. Zacks Investment Research cut shares of Core Laboratories N.V. from a “hold” rating to a “strong sell” rating in a research note on Monday, July 17th. Morgan Stanley reiterated an “overweight” rating and issued a $130.00 target price (down from $150.00) on shares of Core Laboratories N.V. in a research note on Wednesday, June 21st. BidaskClub upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Wednesday, July 5th. Finally, ValuEngine upgraded shares of Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research note on Friday, August 4th. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and five have given a buy rating to the company. Core Laboratories N.V. currently has a consensus rating of “Hold” and an average price target of $110.91.

Core Laboratories N.V. Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply